Ennostar is showcasing miniLED backlighting and fine-pitch RGB miniLED displays at Touch Taiwan 2021, where PlayNitride is exhibiting microLED displays of varying sizes.
Smartization has become a critical initiative to the healthcare industry in recent years. The incorporation of diverse innovative technologies, including LED, has given a boost to...
Apple's supplier of backlight-use miniLED for the vendor's upcoming 12.9-inch iPad Pro will see shipments pick up later in April 2021, according to industry sources.
Ennostar has invested less than NT$3.0 billion (US$106 million) to take an about 10% stake in LED chip and Si-based sensor maker Tyntek, according to industry sources.
China-based Lijing Microelectronics Technology (Jiangsu) will expand monthly miniLED packaging capacity to 800 million chips by the end of May 2021, seven months ahead of schedule,...
III-V compound semiconductor maker Unikorn Semiconductor is expected to undertake outsourced production of microLED panels for LED epitaxial wafer and chip maker Epistar, according...
The miniLED backlighting business is expected to increase Ennostar's monthly consolidated revenues by 20-25%, according to company chairman and CEO Biing-jye Lee at a March 18 investor...
Chipmakers including TSMC and UMC have started buying water by the truckload for their foundries in Southern Taiwan Science Park (STSP), as reservoirs in southern Taiwan face dwindling...
Ennostar will kick off production of miniLED backlight units (BLU) at the end of first-quarter 2021 or in the second quarter, according to industry sources.
LED chipmakers in Taiwan and China have seen their delivery lead times extend, and have raised quotes for some of their products particularly non-blue light LED chips, which in turn...
LED epitaxial wafer and chip maker Epistar has reported NT$1.468 billion (US$51.5 million) in December consolidated revenues, the highest since May 2019 with increases of 3.58% on...
LED epitaxial wafer and chip maker Epistar will recognize NT$3.96 billion (US$138 million) in asset impairment in its 2020 financial report, equivalent to reduction in the net EPS...
